Total Funding
38
13
Total FundingVenture - Series Unknown raised
Growth Score 38 in past quarter
-3 pts
Heat Score 13 in past quarter
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
387684
MolPort distributes chemical compounds to biotech researchers and the scientific community.
Imants Zudans: Founder & CEO- Kristaps Bošs: Operations Manager
About the Company
MolPort sells existing chemical compounds to biotech researchers and the scientific community to speed up drug discovery. Whether it is for biological testing or a reagent to make a key target compound, effectively accessing commercial compounds is a core component of efficient drug discovery.
MolPort was created in 2006 to help scientists
accelerate drug discovery by handling the ordering process of screening compounds and building blocks. Our goal is to help scientists focus on their research, not on procurement. Compound sourcing is a very specific job that requires very specialized expertise and software tools. MolPort specializes in sourcing hundreds or thousands of compounds from dozens of suppliers.
